Sutro Biopharma, Inc. (STRO) Stock News & Chart | StockAdder

(STRO)

Sutro Biopharma, Inc.

Stock chart and latest news for Sutro Biopharma, Inc., tracked under Pharmaceuticals, Biotechnology & Life Sciences in the Health Care sector.

Chart powered byTradingView— professional charts for every trader.Try it free →

Sutro Biopharma, Inc. News

PRO

Sutro Biopharma (STRO) Surges 11.9%: Is This an Indication of Further Gains?

Feb 11, 2026 National Today

Sutro Biopharma Receives 'Moderate Buy' Rating from Analysts

Apr 12, 2026 Investing.com

Leerink Partners initiates Sutro Biopharma stock with outperform rating

Apr 7, 2026 Stock Titan

[EFFECT] SUTRO BIOPHARMA, INC. SEC Filing

Apr 2, 2026 simplywall.st

Sutro Biopharma, Inc.'s (NASDAQ:STRO) Price Is Right But Growth Is Lacking After Shares Rocket 46%

Dec 31, 2025 Quiver Quantitative

Sutro Biopharma Regains Nasdaq Compliance Following Reverse Stock Split

Dec 17, 2025 GuruFocus

STRO Stock: HC Wainwright & Co. Upgrades Sutro Biopharma | STRO

Mar 24, 2026 Yahoo Finance

Sutro Biopharma (STRO) Soars 5.9%: Is Further Upside Left in the Stock?

Jan 22, 2026 Seeking Alpha

Sutro Biopharma: ADC Developer With Poor Track Record Aims For Positive 2026 (NASDAQ:STRO)

Mar 13, 2026 Stock Titan

Sutro says cash lasts to 2028 as cancer drug pipeline advances

Mar 23, 2026 GuruFocus

Analyst James Shin Raises Price Target for Sutro Biopharma (STRO) to $55.00 | STRO Stock News

Mar 25, 2026 Yahoo Finance

Sutro Biopharma, Inc. (NASDAQ:STRO) has caught the attention of institutional investors who hold a sizeable 41% stake